This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Welltower (WELL) Down 0.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Welltower (WELL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mack-Cali's (CLI) Q4 FFO Meets, Revenues Miss Estimates
by Zacks Equity Research
Mack-Cali Realty's (CLI) fourth-quarter 2018 results indicate softness in its office portfolio. In fact, subdued leasing activity and decline in same-store cash net operating income disappoint.
SITE Centers (SITC) Q4 FFO Beats, Revenues Miss Estimates
by Zacks Equity Research
While SITE Centers (SITC) posts better-than-expected results, backed by healthy leasing activity, rent and same-store net operating income (NOI) growth, declining revenues remains a concern.
Lamar Advertising (LAMR) Q4 AFFO Tops Estimates, Revenues Up
by Zacks Equity Research
Lamar Advertising (LAMR) witnesses bottom-line growth on higher revenues and solid operating income in the fourth quarter.
Host Hotels' (HST) Q4 FFO Beats Estimates, Revenues Up Y/Y
by Zacks Equity Research
Host Hotels & Resorts' (HST) Q4 results reflect improvements in food and beverage revenues and productivity gains. Further, year-over-year growth in comparable hotel RevPAR is encouraging.
Should iShares Morningstar Mid-Cap Value ETF (JKI) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for JKI
Welltower (WELL) Misses Q4 FFO Estimates, Reaffirms '19 View
by Zacks Equity Research
Welltower's (WELL) Q4 results reflect healthy same-store net operating income (SSNOI) performance across all of its operating segments.
Welltower (WELL) Misses Q4 FFO Estimates
by Zacks Equity Research
Welltower (WELL) delivered FFO and revenue surprises of -1.94% and 0.48%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
What to Expect From Welltower's (WELL) Earnings This Season
by Zacks Equity Research
While strategic investments across different healthcare property types will likely aid Welltower's (WELL) fourth-quarter performance, higher supply of assets may negatively impact its rental income.
Should iShares Morningstar Mid-Cap Value ETF (JKI) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JKI
Why Trending Outpatient Care is a Boon for Healthcare REITs
by Devyani Chamria
Amid shift of care to low-cost setting, medical office buildings (MOBs) and outpatient facilities have been creating opportunities for healthcare REITs to park their money.
Welltower to Buy CNL Healthcare Properties' Assets for $1.25B
by Zacks Equity Research
Welltower (WELL) will purchase 55 Class A medical office and outpatient facilities from CNL Healthcare Properties to expand its footprint across 16 states.
Should iShares Morningstar Mid-Cap Value ETF (JKI) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for JKI
Welltower Announces $1B Deals, Gets $300M in Equity Capital
by Zacks Equity Research
Welltower's (WELL) buyouts strengthen its existing operator partnerships. Also, with $300 million in common stock investment, Qatar Investment Authority becomes a new equity investor.
Why Is Welltower (WELL) Up 8% Since Last Earnings Report?
by Zacks Equity Research
Welltower (WELL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is it Wise to Hold Welltower Stock in Your Portfolio Now?
by Zacks Equity Research
Welltower's (WELL) strategy to solidify its portfolio in target markets through repositioning efforts bodes well. However, elevated supply of senior housing assets continues to dampen results.
Should iShares Morningstar Mid-Cap Value ETF (JKI) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JKI
Welltower to Build 2nd Seniors Housing Facility in Manhattan
by Zacks Equity Research
Welltower's (WELL) acquisition of a development site at the Upper West Side of Manhattan marks its second venture with Hines to address the aging demography of the region.
Welltower (WELL) in Focus: Stock Moves 5.3% Higher
by Zacks Equity Research
Welltower (WELL) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Welltower (WELL) Q3 FFO and Revenues Beat Estimates, View Up
by Zacks Equity Research
Welltower's (WELL) Q3 results reflect healthy same-store net operating income (SSNOI) performance of the seniors housing triple-net, outpatient medical and long-term/post-acute care segments.
Welltower (WELL) Tops Q3 FFO and Revenue Estimates
by Zacks Equity Research
Welltower (WELL) delivered FFO and revenue surprises of 1.96% and 6.47%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Realty Income (O) in Q3 Earnings?
by Zacks Equity Research
Realty Income (O) Q3 performance is likely to exhibit gains from its focus on tenants from service, non-discretionary and Internet-resilient business despite the choppy retail real estate market.
Host Hotels (HST) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Host Hotels & Resorts (HST) has a solid portfolio of upscale hotels across potential markets and focuses on capital-recycling moves. However, high supply in key markets is likely to affect pricing power.
Why Earnings Season Could Be Great for Welltower (WELL)
by Zacks Equity Research
Welltower (WELL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
CBRE Group (CBRE) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
CBRE Group's (CBRE) Q3 results likely to reflect strength across the company's global regions and growth in global occupier outsourcing business.